PL1778720T3 - Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę - Google Patents

Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę

Info

Publication number: PL1778720T3
Authority: PL; Poland
Prior art keywords: arginine; lysine; antimicrobial peptides; containing motif; amino acids
Prior art date: 2004-08-18

Application number

PL05778505T

Other languages

English (en)

Inventor

Deborah O'neil

Original Assignee

Novabiotics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-18

Filing date

2005-08-18

Publication date

2011-03-31

2004-08-18 Priority claimed from GBGB0418414.9A external-priority patent/GB0418414D0/en

2005-08-18 Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd

2011-03-31 Publication of PL1778720T3 publication Critical patent/PL1778720T3/pl

Links

102000044503 Antimicrobial Peptides Human genes 0.000 title 1
108700042778 Antimicrobial Peptides Proteins 0.000 title 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title 1
239000004472 Lysine Substances 0.000 title 1
150000001413 amino acids Chemical class 0.000 abstract 3
-1 cationic amino acids Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Toxicology (AREA)
Zoology (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

PL05778505T 2004-08-18 2005-08-18 Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę PL1778720T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB0418414.9A GB0418414D0 (en)	2004-08-18	2004-08-18	Peptide
US7979505A	2005-03-14	2005-03-14
PCT/GB2005/003245 WO2006018652A2 (en)	2004-08-18	2005-08-18	Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
EP05778505A EP1778720B1 (en)	2004-08-18	2005-08-18	Antimicrobial peptides comprising an arginine- and/or lysine-containing motif

Publications (1)

Publication Number	Publication Date
PL1778720T3 true PL1778720T3 (pl)	2011-03-31

Family

ID=35907779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05778505T PL1778720T3 (pl)	2004-08-18	2005-08-18	Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę

Country Status (24)

Country	Link
US (4)	US7847059B2 (pl)
EP (5)	EP3141559A1 (pl)
JP (1)	JP5020078B2 (pl)
KR (1)	KR101234780B1 (pl)
CN (3)	CN103360486A (pl)
AT (1)	ATE479704T1 (pl)
AU (1)	AU2005273638B2 (pl)
BR (1)	BRPI0514420B1 (pl)
CA (2)	CA2974538A1 (pl)
CY (1)	CY1113684T1 (pl)
DE (1)	DE602005023315D1 (pl)
DK (2)	DK1927597T3 (pl)
ES (1)	ES2613027T3 (pl)
GB (1)	GB2431404A (pl)
IL (2)	IL180727A (pl)
MX (1)	MX2007002057A (pl)
NO (1)	NO342832B1 (pl)
NZ (2)	NZ553494A (pl)
PL (1)	PL1778720T3 (pl)
PT (2)	PT1778720E (pl)
RU (1)	RU2396273C2 (pl)
SG (3)	SG10201606278UA (pl)
SI (1)	SI1778720T1 (pl)
WO (1)	WO2006018652A2 (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2633435A1 (en)	2004-12-15	2006-06-22	Robert S. Hodges	Antimicrobial peptides and methods of use
EP1976863B1 (en)	2005-12-22	2012-12-12	Novabiotics Limited	Cyclic antimicrobial peptides
AU2012203804B2 (en) *	2005-12-22	2014-10-16	Novabiotics Limited	Cyclic antimicrobial peptides
US9181303B2 (en)	2005-12-22	2015-11-10	Novabiotics Limited	Treatment of bacterial infections with cyclic antimicrobial peptides
GB0702021D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
GB0702022D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
GB0702020D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
HRP20161722T1 (hr) *	2007-07-26	2017-02-10	Revance Therapeutics, Inc.	Antimikrobni peptid i njegovi pripravci
US20100150985A1 (en) *	2008-04-24	2010-06-17	George Just	Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same
GB0817121D0 (en) *	2008-09-18	2008-10-29	Univ St Andrews	Anti-fungal therapy
EP2346521A4 (en) *	2008-10-06	2012-06-20	Univ Colorado Regents	PEPTIDES AND USE METHOD THEREFOR
CN107050442B (zh) *	2008-11-05	2022-09-13	惠氏有限责任公司	用于预防β-溶血链球菌(BHS)疾病的多组分免疫原性组合物
US8303962B2 (en)	2009-01-06	2012-11-06	C3 Jian, Inc.	Antibacterial and antifungal peptides
FR2941231B1 (fr)	2009-01-16	2016-04-01	Sederma Sa	Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
GB0905451D0 (en) *	2009-03-31	2009-05-13	Novabiotics Ltd	Biofilms
EP2437770A4 (en) *	2009-06-05	2013-11-06	Univ Colorado Regents	ANTIMICROBIAL PEPTIDES
JP5664992B2 (ja) *	2009-08-26	2015-02-04	国立大学法人名古屋大学	細胞特異的ペプチド及びその用途
EP2547700A1 (en) *	2010-03-17	2013-01-23	Universität Regensburg	Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein
CN102206250B (zh)	2010-03-29	2017-03-15	翔升科技股份有限公司	低血球溶解性的抗微生物肽、药物组合物及其用途
GB201016733D0 (en)	2010-10-05	2010-11-17	Novabiotics Ltd	Compounds and their use
GB201021186D0 (en)	2010-12-14	2011-01-26	Novabiotics Ltd	Composition
RU2449805C1 (ru)	2011-01-27	2012-05-10	Общество С Ограниченной Ответственностью "Гармония"	Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
CN103547296B (zh)	2011-03-11	2016-08-17	非营利性组织佛兰芒综合大学生物技术研究所	用于抑制和检测蛋白质的分子和方法
DE102011077071A1 (de) *	2011-06-07	2012-12-13	Beiersdorf Ag	Wirkstoffkombinationen aus Epsilon-Polylysin und Climbazol
KR101345333B1 (ko) *	2011-12-30	2013-12-30	조선대학교산학협력단	라이신 및 트립토판 잔기가 ４번 반복된 신규한 항균 및 항진균 펩타이드 및 이의 용도
GB201204457D0 (en) *	2012-03-14	2012-04-25	Novabiotics Ltd	Polypeptides and their use
WO2013142184A1 (en)	2012-03-19	2013-09-26	Yale University	Antimicrobial compositions and methods
KR102266659B1 (ko)	2012-03-23	2021-06-17	아미크로베, 인코포레이티드.	조직-적합성 특성을 갖는 항균물질의 조성물 및 용도
MX370929B (es)	2012-10-28	2020-01-08	Revance Therapeutics Inc	Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
WO2014130655A2 (en)	2013-02-20	2014-08-28	Biolog, Inc.	Compositions and methods to inactivate and/or reduce production of microbial toxins
RU2683651C2 (ru) *	2013-06-18	2019-04-01	Иван Дмитриевич Захаров	Лекарственное средство для лечения кератоконуса и других дегенеративных заболеваний роговицы и фармацевтические препараты на его основе
GB201409451D0 (en)	2014-05-28	2014-07-09	Ipabc Ltd	Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
WO2015195458A1 (en) *	2014-06-17	2015-12-23	Albert Einstein College Of Medicine, Inc.	Therapeutic nanoparticles and methods thereof
US11484580B2 (en)	2014-07-18	2022-11-01	Revance Therapeutics, Inc.	Topical ocular preparation of botulinum toxin for use in ocular surface disease
GB201416727D0 (en) *	2014-09-22	2014-11-05	Novabiotics Ltd	Use
CN104311627B (zh) *	2014-10-29	2018-04-10	中山大学	一种抗菌肽的合成方法和应用
EP3106172B1 (de) *	2015-06-15	2020-08-05	B. Braun Melsungen AG	Antimikrobiell aktive mittel und deren verwendung
JP2019510076A (ja) *	2016-02-19	2019-04-11	フォルシュングスツェントルムボルシュテルライプニッツツェントルムフュールメディツィンウントビオヴィッセンシャフテン	細菌感染症を治療するための手段と方法
PT3554474T (pt)	2016-12-16	2024-02-12	Baxter Healthcare Sa	Composições de micafungina
WO2018144545A1 (en)	2017-01-31	2018-08-09	Stc.Unm	Arginine-rich polypeptide compositions and methods of using same
AU2018249552A1 (en)	2017-04-06	2019-10-31	Amicrobe, Inc.	Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US11931333B1 (en) *	2019-05-28	2024-03-19	Peter Van Horn	Topical treatment of herpes infections
CN112457375B (zh) *	2019-09-06	2022-12-02	韩苏	多肽化合物及其制备方法与应用
CN113264987B (zh) *	2021-05-31	2023-11-17	安徽农业大学	具有抗真菌和清除自由基活性的环色-苏-缬-异亮-亮肽及制备方法
CN113307848B (zh) *	2021-05-31	2023-11-17	安徽农业大学	具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽及制备方法
TW202317598A (zh) *	2021-09-01	2023-05-01	美商艾姆麥克斯治療股份有限公司	具有抗微生物活性的胜肽
CN115669843A (zh) *	2022-10-26	2023-02-03	中国农业大学	一种采用高压微射流结合混合肽有效杀灭芽孢的方法
CN116332777A (zh) *	2023-02-20	2023-06-27	华中科技大学	二芳基苯甲胺类化合物、制备及作为载体合成多肽的应用
GB202311426D0 (en) *	2023-07-25	2023-09-06	Novabiotics Ltd	Cosmetic nail formulations
GB202400182D0 (en) *	2024-01-05	2024-02-21	Novabiotics Ltd	Improved compositions to improve the appearance and/or condition of skin, scalp, nail and/or hair
WO2026038945A1 (en) *	2024-08-16	2026-02-19	Winnox Cosmeceutics Sdn. Bhd.	Peptides, compositions and methods of use
CN119235837B (zh) *	2024-12-02	2025-03-25	温州医科大学附属第一医院	一种专用于抗浅部真菌细菌感染的组合物及其制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3561444A (en)	1968-05-22	1971-02-09	Bio Logics Inc	Ultrasonic drug nebulizer
US3703173A (en)	1970-12-31	1972-11-21	Ted A Dixon	Nebulizer and tent assembly
US4051842A (en)	1975-09-15	1977-10-04	International Medical Corporation	Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de)	1976-06-11	1980-01-31	Siemens Ag, 1000 Berlin Und 8000 Muenchen	Implantierbare Dosiereinrichtung
EP0062063B1 (de)	1980-10-14	1985-04-17	Maschinenfabrik Rieter Ag	Spinnmaschine, insbesondere ringspinnmaschine
US4383529A (en)	1980-11-03	1983-05-17	Wescor, Inc.	Iontophoretic electrode device, method and gel insert
US4635627A (en)	1984-09-13	1987-01-13	Riker Laboratories, Inc.	Apparatus and method
US4624251A (en)	1984-09-13	1986-11-25	Riker Laboratories, Inc.	Apparatus for administering a nebulized substance
US4962091A (en)	1986-05-23	1990-10-09	Syntex (U.S.A.) Inc.	Controlled release of macromolecular polypeptides
DE59009460D1 (de) *	1989-05-30	1995-09-07	Siemens Ag	CMOS-ECL-Wandler.
CA2061862A1 (en) *	1991-03-04	1992-09-05	Jonathan Duvick	Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms
JP3022615B2 (ja) *	1991-03-13	2000-03-21	日清製粉株式会社	ε−ポリリジンの製造方法
JP3000490B2 (ja) *	1991-04-08	2000-01-17	チッソ株式会社	抗白癬菌剤
WO1994007529A1 (en)	1992-09-25	1994-04-14	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5486503A (en) *	1991-11-01	1996-01-23	The Trustees Of Boston University	Anti-fungal histatin-based peptides
JP3655359B2 (ja) *	1995-06-29	2005-06-02	株式会社サンコンタクトレンズ	含水性ソフトコンタクトレンズの洗浄および消毒用組成物
US5714577A (en) *	1996-01-26	1998-02-03	University Of Pittsburgh	Antimicrobial peptides
US6503881B2 (en) *	1996-08-21	2003-01-07	Micrologix Biotech Inc.	Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
JPH11113779A (ja) *	1997-10-14	1999-04-27	Asahi Chem Ind Co Ltd	除菌ウェットティッシュ
HUP0200897A2 (en) *	1999-04-15	2002-08-28	Lilly Co Eli	Antifungal agents isolated from pseudomonas syringae
US20020001582A1 (en) *	1999-04-21	2002-01-03	Charter Edward A.	Methods and compositions for inhibiting microbial growth
JP2001264707A (ja) *	2000-03-22	2001-09-26	Chisso Corp	コンタクトレンズ用消毒保存用溶液
JP2002020320A (ja) *	2000-06-30	2002-01-23	Santen Pharmaceut Co Ltd	点眼液用防腐剤
FR2811666B1 (fr) *	2000-07-13	2005-04-01	Entomed S A	Peptides antifongiques et/ou antibacteriens, leurs preparations et les compositions les contenant
CN1336383A (zh) *	2000-07-29	2002-02-20	中国科学院昆明动物研究所	大蹼铃蟾抗菌肽及其制备方法和在制药中的应用
RU2183643C1 (ru) *	2000-12-18	2002-06-20	Государственный научно-исследовательский институт особо чистых биопрепаратов	Пептид, обладающий биоцидной активностью
US7033991B2 (en) *	2001-07-16	2006-04-25	Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College	Inhibiting furin with polybasic peptides
ATE489462T1 (de) *	2002-04-25	2010-12-15	Toagosei Co Ltd	Antimikrobielles polypeptid und nutzung davon
JP4461727B2 (ja) *	2003-07-18	2010-05-12	チッソ株式会社	外用剤組成物
US20080193616A1 (en) *	2007-02-13	2008-08-14	The Coca-Cola Company	Beverage compositions comprising polylysine and at least one weak acid

2005
- 2005-08-18 MX MX2007002057A patent/MX2007002057A/es active IP Right Grant
- 2005-08-18 SG SG10201606278UA patent/SG10201606278UA/en unknown
- 2005-08-18 PT PT05778505T patent/PT1778720E/pt unknown
- 2005-08-18 DK DK08001112.5T patent/DK1927597T3/en active
- 2005-08-18 SG SG2013007356A patent/SG188092A1/en unknown
- 2005-08-18 US US11/573,770 patent/US7847059B2/en not_active Expired - Lifetime
- 2005-08-18 WO PCT/GB2005/003245 patent/WO2006018652A2/en not_active Ceased
- 2005-08-18 PT PT80011125T patent/PT1927597T/pt unknown
- 2005-08-18 NZ NZ553494A patent/NZ553494A/en not_active IP Right Cessation
- 2005-08-18 SG SG200905379-4A patent/SG155211A1/en unknown
- 2005-08-18 PL PL05778505T patent/PL1778720T3/pl unknown
- 2005-08-18 BR BRPI0514420-5A patent/BRPI0514420B1/pt not_active IP Right Cessation
- 2005-08-18 EP EP16176481.6A patent/EP3141559A1/en not_active Withdrawn
- 2005-08-18 NZ NZ584340A patent/NZ584340A/en not_active IP Right Cessation
- 2005-08-18 EP EP16179810.3A patent/EP3147293B1/en not_active Expired - Lifetime
- 2005-08-18 CA CA2974538A patent/CA2974538A1/en not_active Abandoned
- 2005-08-18 DE DE602005023315T patent/DE602005023315D1/de not_active Expired - Lifetime
- 2005-08-18 CN CN2013101618914A patent/CN103360486A/zh active Pending
- 2005-08-18 DK DK05778505.7T patent/DK1778720T3/da active
- 2005-08-18 CN CN2005800281216A patent/CN101031583B/zh not_active Expired - Fee Related
- 2005-08-18 ES ES08001112.5T patent/ES2613027T3/es not_active Expired - Lifetime
- 2005-08-18 AU AU2005273638A patent/AU2005273638B2/en not_active Ceased
- 2005-08-18 CA CA2575058A patent/CA2575058C/en not_active Expired - Lifetime
- 2005-08-18 SI SI200531161T patent/SI1778720T1/sl unknown
- 2005-08-18 RU RU2007109518/04A patent/RU2396273C2/ru active
- 2005-08-18 JP JP2007526571A patent/JP5020078B2/ja not_active Expired - Fee Related
- 2005-08-18 CN CN2013101617432A patent/CN103360485A/zh active Pending
- 2005-08-18 AT AT05778505T patent/ATE479704T1/de active
- 2005-08-18 EP EP09005438A patent/EP2096118A1/en not_active Withdrawn
- 2005-08-18 EP EP05778505A patent/EP1778720B1/en not_active Expired - Lifetime
- 2005-08-18 EP EP08001112.5A patent/EP1927597B1/en not_active Expired - Lifetime
- 2005-08-18 KR KR1020077003571A patent/KR101234780B1/ko not_active Expired - Fee Related
2007
- 2007-01-16 IL IL180727A patent/IL180727A/en active IP Right Grant
- 2007-02-19 GB GB0703060A patent/GB2431404A/en not_active Withdrawn
- 2007-03-14 NO NO20071369A patent/NO342832B1/no unknown
2010
- 2010-09-29 US US12/893,663 patent/US8088888B2/en not_active Expired - Lifetime
- 2010-11-30 CY CY20101101093T patent/CY1113684T1/el unknown
2011
- 2011-06-02 IL IL213319A patent/IL213319A/en not_active IP Right Cessation
- 2011-06-28 US US13/170,975 patent/US8350003B2/en not_active Expired - Fee Related
- 2011-11-30 US US13/308,479 patent/US8470769B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20110021415A1 (en)	2011-01-27
NO342832B1 (no)	2018-08-13
US20070244044A1 (en)	2007-10-18
PT1778720E (pt)	2010-11-29
IL180727A (en)	2015-06-30
GB0703060D0 (en)	2007-03-28
SG155211A1 (en)	2009-09-30
EP1778720A2 (en)	2007-05-02
SG188092A1 (en)	2013-03-28
IL180727A0 (en)	2007-06-03
WO2006018652A3 (en)	2006-07-13
US8470769B2 (en)	2013-06-25
AU2005273638A1 (en)	2006-02-23
MX2007002057A (es)	2007-07-19
EP3147293B1 (en)	2022-05-04
IL213319A0 (en)	2011-07-31
US7847059B2 (en)	2010-12-07
CY1113684T1 (el)	2016-06-22
US8350003B2 (en)	2013-01-08
CN101031583B (zh)	2013-06-05
DK1778720T3 (da)	2010-11-29
DK1927597T3 (en)	2017-02-13
RU2396273C2 (ru)	2010-08-10
RU2007109518A (ru)	2008-09-27
EP1927597A1 (en)	2008-06-04
ATE479704T1 (de)	2010-09-15
US8088888B2 (en)	2012-01-03
US20120071398A1 (en)	2012-03-22
CA2575058C (en)	2017-09-12
NZ584340A (en)	2010-09-30
SG10201606278UA (en)	2016-09-29
US20110269673A1 (en)	2011-11-03
BRPI0514420B1 (pt)	2022-05-17
GB2431404A (en)	2007-04-25
NZ553494A (en)	2010-07-30
EP1778720B1 (en)	2010-09-01
WO2006018652A2 (en)	2006-02-23
CA2974538A1 (en)	2006-02-23
IL213319A (en)	2017-07-31
EP3141559A1 (en)	2017-03-15
BRPI0514420A (pt)	2008-06-10
DE602005023315D1 (de)	2010-10-14
EP1927597B1 (en)	2016-11-02
HK1105982A1 (en)	2008-02-29
AU2005273638B2 (en)	2011-09-29
CN103360485A (zh)	2013-10-23
CA2575058A1 (en)	2006-02-23
CN103360486A (zh)	2013-10-23
KR20070083486A (ko)	2007-08-24
NO20071369L (no)	2007-05-04
EP2096118A1 (en)	2009-09-02
PT1927597T (pt)	2017-02-10
ES2613027T3 (es)	2017-05-22
JP2008509980A (ja)	2008-04-03
SI1778720T1 (sl)	2011-04-29
JP5020078B2 (ja)	2012-09-05
KR101234780B1 (ko)	2013-02-20
CN101031583A (zh)	2007-09-05
EP3147293A1 (en)	2017-03-29

Publication	Publication Date	Title
SI1778720T1 (sl)	2011-04-29	Antimikrobni peptidi obsegajoč arginin in/ali lizin vsebujoč motiv
NZ595037A (en)	2013-07-26	Inhibition of biofilm organisms by combination of cysteamine and repetitive peptides
EP2455462A3 (en)	2013-05-29	Lipase variants for pharmaceutical use
WO2005012347A3 (en)	2005-04-14	Novel insulin derivatives
WO2010026010A3 (de)	2011-05-26	Haarbehandlungsmittel mit niedrigdosierten oligopeptiden
WO2009004315A8 (en)	2009-07-16	Isolated peptides and uses thereof
ATE506957T1 (de)	2011-05-15	Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
CY1110185T1 (el)	2015-01-14	Τροποποιημενη πρωτεϊνη vp1-καψιδιου του παρβοϊου β19
EP1930024A3 (en)	2008-08-06	G-CSF solution formulations having long-term stability
WO2005039626A3 (en)	2005-06-16	Use of hydroxylated amino acids for treating diabetes
WO2008047370A3 (en)	2008-06-19	Compositions and methods for inducing angiogenesis
MY147920A (en)	2013-02-15	Antibacterial and antiviral peptides from actinomadura namibiensis
WO2010057242A3 (de)	2010-09-16	Vakzin
WO2003059323A3 (de)	2004-03-11	Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii
WO2007068240A3 (de)	2008-04-10	Peptide für die wechselwirkung mit alpha-helikalen coiled-coil-strukturen und/oder coiled-coil-sequenzen, davon abgeleitete mittel und ihre verwendung
WO2007093848A3 (en)	2008-02-28	Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori
UA96564C2 (en)	2011-11-25	Peptide
WO2003020749A3 (en)	2004-03-25	Ncam binding compounds
MX2010005597A (es)	2010-10-25	Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos.
WO2002055481A8 (en)	2003-10-02	Prodrugs of excitatory amino acids
WO2004052916A3 (en)	2004-09-16	Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids
WO2007066018A3 (fr)	2007-07-26	Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
EP1312608A3 (en)	2003-06-18	Discodermolide analogues and their pharmaceutical use
WO2003095482A3 (fr)	2004-04-08	Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.
WO2002030874A3 (en)	2002-07-25	Aliphatic, cyclic amino carboxylic acids as integrin antagonists